Interpace Diagnostics Issues Update Regarding Announced Contract with BCBS of Massachusetts Mar 11, 2020
Interpace Biosciences Announces Acceptance of first paper Demonstrating Clinical Performance of ThyGeNEXT with ThyraMIR Mar 2, 2020
Interpace Biosciences Announces Addition to Board of Directors and Changes in Leadership Jan 30, 2020
Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners Jan 13, 2020
Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett’s Esophagus Jan 6, 2020
Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT® Dec 17, 2019
Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China Dec 5, 2019
